Short answer
Incyte (INCY) filed an 8-K current report with the SEC on June 22, 2026 reporting Item 8.01 (Other Events). CMS settlement excludes Opzelura from Jakafi’s Medicaid line-extension rules.
Incyte 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- CMS settlement excludes Opzelura from Jakafi’s Medicaid line-extension rules
- Approximately $246 million non-cash benefit expected in Q2 2026 from reversing prior accruals
- Opzelura gross-to-net expected to improve as future line-extension accruals end
- Guidance update planned with Incyte’s next earnings release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Incyte 8-K filings
Get the next INCY 8-K as it lands
Follow INCY for push alerts, or ask the research agent what this filing means.